Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack McCain

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Biotechnology Healthcare|February 21, 2013
Does race have a place in biotechnological research?Jack McCain
Biotechnology Healthcare|February 21, 2013
The cancer genome atlas: new weapon in old war?Jack McCain
Managed Care (Langhorne, Pa.)|December 15, 2012
Hospital at home saves 19% in real-world studyJack McCain
Biotechnology Healthcare|February 9, 2013
The future of gene therapyJack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|April 20, 2013
The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic MelanomaJack McCain
Managed Care (Langhorne, Pa.)|July 21, 2004
P&T committees in position to reduce medication errorsJack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: new and emerging treatment optionsJack McCain
Managed Care (Langhorne, Pa.)|May 19, 2004
Statin therapy: more than meets the eye?Jack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|August 4, 2015
First-in-Class CDK4/6 Inhibitor Palbociclib Could Usher in a New Wave of Combination Therapies for HR+, HER2- Breast CancerJack McCain
Biotechnology Healthcare|February 2, 2013
Renewing the assault on mRNAJack McCain
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Biotechnology Healthcare|February 21, 2013
Does race have a place in biotechnological research?Jack McCain
Biotechnology Healthcare|February 21, 2013
The cancer genome atlas: new weapon in old war?Jack McCain
Managed Care (Langhorne, Pa.)|December 15, 2012
Hospital at home saves 19% in real-world studyJack McCain
Biotechnology Healthcare|February 9, 2013
The future of gene therapyJack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|April 20, 2013
The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic MelanomaJack McCain
Managed Care (Langhorne, Pa.)|July 21, 2004
P&T committees in position to reduce medication errorsJack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|March 27, 2014
Drugs that offer a survival advantage for men with bone metastases resulting from castration-resistant prostate cancer: new and emerging treatment optionsJack McCain
Managed Care (Langhorne, Pa.)|May 19, 2004
Statin therapy: more than meets the eye?Jack McCain
P & T : a Peer-Reviewed Journal for Formulary Management|August 4, 2015
First-in-Class CDK4/6 Inhibitor Palbociclib Could Usher in a New Wave of Combination Therapies for HR+, HER2- Breast CancerJack McCain
Biotechnology Healthcare|February 2, 2013
Renewing the assault on mRNAJack McCain
Pageof 3